Drug Trial Radar · NCT04987658
Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder
Last checked: Nov 19, 2026Latest source record: Nov 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7
Actual
Start
Jul 22, 2021
Primary completion
Aug 11, 2023
Study completion Aug 11, 2023
Sponsor
- Lead sponsor
- Alkermes, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 3, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 10 years, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety, tolerability, and pharmacokinetics of olanzapine and samidorphan in clinically stable pediatric subjects (10 to 12 years old) with Bipolar I disorder following oral administration of multiple ascending doses of OLZ/SAM
Conditions
- Bipolar I Disorder
Interventions
OLZ/SAMDrug
Olanzapine and Samidorphan taken once daily over a max period of 21 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum plasma concentration observedTime frame: Up to 3 weeks
- Area under the plasma concentration-time curve over the 24-hour dosing intervalTime frame: Up to 3 weeks
- Time to reach maximum concentrationTime frame: Up to 3 weeks
- Incidence of Adverse EventsTime frame: Up to 6 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Alkermes Investigational Site
Decatur, Georgia
Alkermes Clinical Investigative Site
Cincinnati, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.